MIODx® is pioneering the discovery of early detection and prognostic cancer biomarkers through the company’s proprietary platforms. The company’s VerifyDx™ platform utilizes a multiplex PCR assay and advanced bioinformatics to interrogate multiple DNA and RNA pathways that are implicated in highly metastatic cancer. In addition to the VerifyDx™ platform, the ClonoMap platform is able to generate information on T and B Cell diversity that can be applied to monitoring a patient’s response to immunotherapy, used to discover new targets for drug companies, or as a way to profile an individual’s adaptive immune system over time.
Job Openings with miodx
We currently do not have any open positions, but please check back soon.
Join our Talent Network to be considered for future opportunities at miodx